AdaptHealth Corp. AHCO

Healthcare · Medical Devices · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$608.83M
Market Cap
$819.86M
Margin of Safety
-34.7%
Intrinsic / Market Ratio
0.74

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

514.90M USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

244.09M USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

1.07B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

608.83M USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

608.83M USD

from the sum above

Market Cap

819.86M USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.74×

the ratio the screener ranks by; Margin of Safety -34.7% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 514.90M USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)2.54B USD
−②Net Debt Today2.02B USD
+③Growth Value0 USD
=Value514.90M USD

EPV of the Operations (NOPAT over WACC)

2.54B USD

Net debt today

-2.02B USD

Growth Value

0 USD

Value

514.90M USD

①EPV (earnings power value)

2.54B USD

②Net Debt Today

2.02B USD

③Growth Value

0 USD

Market value

Market Cap819.86M USD

Today's price times the shares.

Value vs market

Margin of Safety-59.2%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 244.09M USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE17.59M USD
+②Equity at Year 15, Today226.50M USD
=Value244.09M USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment rising to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

17.59M USD

②Equity at Year 15, Today

226.50M USD

Market value

Market Cap819.86M USD

Today's price times the shares.

Value vs market

Margin of Safety-235.9%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 1.07B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF1.62B USD
+②Invested Capital at Year 15, Today1.47B USD
−③Net Debt Today2.02B USD
=Value1.07B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment rising to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

1.62B USD

②Invested Capital at Year 15, Today

1.47B USD

③Net Debt Today

2.02B USD

Market value

Market Cap819.86M USD

Today's price times the shares.

Value vs market

Margin of Safety+23.2%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 6.44%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 1.42×Market Risk Premium 6.00%= 13.00%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC 25.00% (default): the statements print a tax provision of 50.93M USD on a pretax income of -15.17M USD, which gives no rate between 0 and the profit before tax, so the 25% default stands for the tax the interest saves.

Interest Expense =EBIT 90.69M USD−Pretax Income -15.17M USD= 105.86M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 105.86M USDTotal Debt 2.07B USD×(1 − Tax Rate for WACC 25.00%)= 3.84%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 2.07B USDMarket Cap + Total Debt 819.86M USD + 2.07B USD= 71.60%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 28.40%×Cost of Equity 13.00%+Debt Weight 71.60%×Cost of Debt 3.84%= 6.44%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 4.35B USD − Total Liabilities 2.96B USD = Book Value Today 1.39B USD

Total Debt 2.07B USD − Cash and Short-Term Investments 43.33M USD = Net Debt Today 2.02B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 10.6%at most 5%passes133,370,040 / 132,634,850
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets15.5%at least -10.0%passes(602.37M USD − -70.86M USD) ÷ 4.35B USD
Price to bookMarket Cap ÷ Book Value Today0.59×at most 3×passes819.86M USD ÷ 1.39B USD
Operating marginOperating Income ÷ Revenue5.7%above 10.0%does not pass186.45M USD ÷ 3.25B USD
Revenue growthRevenue ÷ Revenue a Year Before − 1-0.5%above 10.0%does not pass3.25B USD / 3.26B USD
Net cash(Cash − Total Debt) ÷ Market Cap-246.8%above -30%does not pass(43.33M USD − 2.07B USD) ÷ 819.86M USD
Operating efficiencyOperating Income ÷ Gross Profit30.6%above 25.0%passes186.45M USD ÷ 609.81M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

6 USD

Enterprise value

2.84B USD

market cap plus net debt

EV / EBITDA

4.86×

Price / book

0.58×

the provider's book

Price / earnings

—

Return on equity

-15.2%

the provider's, not the engine's

Profit margin

-6.8%

Revenue growth

12.7%

Analyst target, mean

9 USD

Analysts

7

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

2.97B3.20B3.26B3.25B

Gross profit

580.70M624.69M681.77M609.81M

Operating income

190.60M232.62M277.09M186.45M

EBITDA

operating income before depreciation and amortisation

559.05M-210.91M628.65M473.00M

Pretax income

98.00M-724.51M136.16M-15.17M

Net income

69.39M-679.57M90.51M-70.86M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

56.56M63.32M98.42M4.57M

R&D

————
Balance sheet, year end

Total assets

5.22B4.51B4.49B4.32B

Total liabilities

3.06B3.05B2.91B2.79B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

2.15B1.46B1.57B1.52B

Total debt

2.33B2.30B2.13B1.90B

Cash and equivalents

46.32M77.21M109.86M106.24M

Net PP&E

fixed assets after depreciation

622.63M638.17M618.97M674.90M

Working capital

current assets less current liabilities

129.22M112.14M188.99M16.52M
Cash flow

Operating cash flow

374.24M481.15M542.38M602.37M

Capital expenditure

paid out, so below zero

-391.81M-337.80M-306.36M-382.77M

Depreciation and amortisation

351.53M383.17M365.70M382.31M

Free cash flow

operating cash flow plus capital expenditure

-17.57M143.35M236.02M219.60M